Post by BBS Automation Life Sciences

The next decade of drug delivery may already be taking shape. And it is increasingly centered around the prefilled syringe. Few segments in MedTech are experiencing the sustained growth and investment seen in prefilled syringes. Driven by biologics, self-administration trends, chronic disease management, and patient convenience, prefilled syringes continue to transform how therapies are delivered worldwide. Yet behind every successful product is a manufacturing challenge. Manufacturers must balance: 💉 Precision assembly 💉 Sensitive component handling 💉 Needle protection 💉 Traceability requirements 💉 Functional verification 💉 Validation readiness 💉 Future scalability As demand continues to increase, manufacturing strategies must evolve beyond today’s production needs and prepare for tomorrow’s growth. At BBS Automation, we see prefilled syringes as one of the most influential platforms shaping the future of drug delivery. What do you believe will be the biggest driver of growth in the prefilled syringe market over the next decade? Join us each week for MEDTECH THURSDAYS as we explore the technologies, manufacturing strategies, and commercialization journeys shaping the future of healthcare. From Proof of Principle to Global Production and Scalability, we'll share insights into how innovation and manufacturing readiness come together to bring life-changing products to patients. #PrefilledSyringes #DrugDelivery #MedicalDevices #LifeSciences #MedTechThursday #BBSAutomation Dürr Group

Video Content